Introduction
Living with HIV requires ongoing treatment, regular medical care, and long-term medication adherence. Thanks to advances in antiretroviral therapy, many people living with HIV can achieve and maintain viral suppression, helping protect their immune system and support long-term health. However, the cost of treatment can create financial challenges for some patients, especially when therapy is needed indefinitely.
Dovato is a prescription antiretroviral medication that combines two HIV medicines into a complete once-daily treatment regimen. By targeting HIV replication through two different mechanisms, Dovato helps lower viral load and maintain viral suppression when taken consistently as prescribed. The medication may be used in certain newly diagnosed patients as well as eligible individuals who are already virologically suppressed and transitioning from another HIV treatment regimen.
Because Dovato is a brand-name HIV medication, treatment costs can be substantial without insurance coverage or financial assistance. Many patients researching the Dovato patient assistance program are seeking ways to reduce prescription costs while maintaining access to treatment.
Prescription Hope offers access to affordable medications through patient assistance programs.
What Is the Dovato Patient Assistance Program?
Understanding Dovato Prescription Assistance
Medications like Dovato are often too expensive for the average American to afford without adequate insurance coverage. To help offset medication costs, patients look for ways to save.
Pharmaceutical manufacturers often launch Patient Assistance Programs that provide access to affordable brand-name medications for qualified patients.
Getting help paying for Dovato through the Dovato Patient Assistance Program could be the answer qualified patients need; however, some patient assistance programs come with some difficulties.
How Expert Advocates Help Make Dovato More Affordable
Personalized Medication Assistance
Unfortunately, some patient assistance program application processes are complex and hard to navigate. With extensive forms, lots of documents to collect, required signatures, and communication requirements, patients have been known to give up on the application process.
Prescription Hope’s team of patient advocates is your prescription assistance specialists. They support you throughout the entire process by completing forms, collecting all documents and signatures, communicating with healthcare providers, and coordinating with manufacturers.
Getting Dovato enrollment assistance is as simple as enrolling with Prescription Hope.
Ongoing Patient Support
Prescription Hope’s patient-centered support doesn’t end with patient assistance program application assistance. Our expert patient advocates continue to provide long-term medication assistance services, handling refill schedules, document updates, yearly renewals, and much more.
Dovato Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating HIV Medication Costs
Plus, Prescription Hope’s prescription access solutions are affordable for Americans who struggle financially. Our service rate is a simple $70.00 per month, per medication.
Our patients enjoy knowing they’ll never deal with hidden fees, add-on charges, or medication costs.
Those seeking Dovato cost assistance enjoy our specialized antiretroviral medication support services at a simple, low monthly rate.
Dovato Patient Assistance Eligibility
General Eligibility Requirements
Every patient assistance program maintains certain requirements for qualification. Some general criteria categories include:
Insurance: Each program sets individual insurance coverage standards. Some require no insurance, while others allow for inadequate or expensive coverage.
Income: Every program maintains its own income threshold requirements.
Prescription: All programs require a qualified patient to have a valid prescription for the brand-name medication they wish to get at a low cost.
US Residency: All qualified patients must be legal US residents.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Prescription Hope’s patient assistance registration and support services help those who need affordable medications enroll in patient assistance programs. To enroll in Dovato assistance, patients can follow Prescription Hope’s 6 simple steps:
- Submit Information: Our enrollment form only takes a few minutes to complete.
- Advocate Contact: A patient advocate will contact you within 1-2 business days after you submit your enrollment form.
- Document Collection: After we prequalify you, our patient advocates will collect documents required for your application.
- Provider Coordination: Due to signature requirements, our team will also contact your healthcare providers to secure all necessary signatures.
- Program Submission: Once everything is in order, we submit your application to the manufacturer’s patient assistance program.
- Medication Delivery: Following approval, patients typically receive their medications within 2 weeks. All medications ship directly from the manufacturer to a patient’s door or doctor’s office.
Prescription Hope is a medication access service and therefore does not handle medications at any time.
Understanding Dovato
How Dovato Works
Dovato combines two antiretroviral medications, dolutegravir and lamivudine, into a single tablet taken once daily. These medications work together to block HIV replication through two different mechanisms.
Dolutegravir is an integrase strand transfer inhibitor (INSTI). It blocks the HIV integrase enzyme, which the virus uses to insert its genetic material into human cells. By preventing this step, dolutegravir helps stop HIV from establishing new infections within cells.
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI). It works by blocking reverse transcriptase, another enzyme HIV needs to make copies of itself. Together, these medications help reduce HIV replication, lower viral load, and maintain immune system function.
Although Dovato does not cure HIV, it can help patients achieve and maintain long-term viral suppression when taken consistently as prescribed.
What Conditions Does Dovato Treat?
Dovato is FDA-approved for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older who weigh at least 25 kg (55 pounds).
The medication may be used as a complete treatment regimen in individuals who have not previously received antiretroviral therapy. It may also be used as a replacement regimen for certain patients who are already virologically suppressed on a stable HIV treatment plan and have no history of treatment failure or known resistance to either component of Dovato.
Dovato is not approved for HIV prevention, including pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP). Healthcare providers evaluate multiple factors when determining whether Dovato is an appropriate treatment option, including viral load, resistance testing results, and hepatitis B status.
Benefits of Treatment
Dovato offers several potential benefits for eligible patients living with HIV-1 infection. As a complete two-drug antiretroviral regimen, it provides effective HIV treatment in a single once-daily tablet.
Potential benefits include achieving and maintaining viral suppression, reducing the amount of HIV in the bloodstream, preserving immune system function, and supporting long-term disease management. The once-daily dosing schedule may also help simplify treatment and support medication adherence for some patients.
Clinical studies have demonstrated that Dovato can help appropriate patients achieve and maintain virologic suppression. Effective HIV treatment may also help reduce the risk of HIV-related complications and support overall health outcomes when used as part of a comprehensive treatment plan.
Important Safety Information and Side Effects
Dovato carries an FDA Boxed Warning regarding severe acute exacerbations of hepatitis B virus infection in patients who are coinfected with HIV-1 and hepatitis B. Because lamivudine is active against hepatitis B, discontinuing treatment may lead to worsening liver disease in affected patients. Hepatitis B testing is recommended before starting treatment, and appropriate monitoring may be required if therapy is stopped.
Common side effects include headache, diarrhea, nausea, insomnia, fatigue, anxiety, and dizziness. Many patients tolerate Dovato well, but side effects can vary among individuals.
Serious hypersensitivity reactions have been reported with dolutegravir-containing medications. Symptoms may include rash, fever, facial swelling, difficulty breathing, liver abnormalities, and other signs of organ involvement. Treatment should be stopped immediately if a serious allergic reaction is suspected.
Additional warnings include liver toxicity, immune reconstitution syndrome, depression, anxiety, mood changes, suicidal thoughts or behaviors, and pancreatitis. Patients should promptly report significant mood changes, severe abdominal pain, persistent nausea, vomiting, or symptoms of liver problems.
Important drug interactions may occur with dofetilide, certain anticonvulsants, rifampin and related medications, iron supplements, calcium supplements, aluminum- or magnesium-containing antacids, and St. John’s wort. Patients should discuss all medications, vitamins, and supplements with their healthcare provider before starting treatment.
Dovato may be used during pregnancy in certain situations, and patients who are pregnant or planning pregnancy should discuss treatment options with their healthcare provider. In the United States, individuals with HIV are generally advised not to breastfeed because of the risk of HIV transmission to the infant.
Regular monitoring during treatment may include HIV viral load testing, CD4 cell counts, liver function tests, kidney function assessments, hepatitis B screening, and evaluation of treatment adherence and tolerability.
Access to Multiple Medications
Support Beyond Dovato
Those in need of HIV medication support often also need multiple medication assistance programs to help cover their other medication costs.
Prescription Hope’s services remain $70.00 per month, per medication, no matter how many medications a patient qualifies for on our list of hundreds of brand-name medications.
Why Choose Prescription Hope for Dovato Assistance
Patient-Focused Medication Support
Our prescription affordability support has helped patients across the nation access low-cost medications for 20 years.
Simplified Access to Specialty Therapies
We don’t just offer prescription assistance. We take care of the administrative tasks related to prescription assistance. Our team manages things like refill schedules, document updates, and yearly renewals.
Ongoing Prescription Assistance
Our affordable Dovato access and specialty medication assistance continue for as long as a patient is with us. For $70.00 per month, per medication, we support our patients and advocate on their behalf with all things related to their patient assistance program.
Those who wish to apply for the Dovato Patient Assistance Program can enroll with Prescription Hope today and find out how they can save on their monthly medication costs!
